Eating Before Taking CBD Triples How Much Your Body Absorbs

Randomized, single-dose, two-arm (fasting and fed), open-label pharmacokinetic trial. 18 healthy male subjects (9 per arm) received 300 mg of nanodispersible CBD oral solution. Plasma concentrations of CBD and metabolites (7-OH-CBD, 7-COOH-CBD) were quantified at multiple timepoints. Pharmacokinetic parameters analyzed using non-compartmental modeling.

CBD's poor and variable oral bioavailability is one of the biggest practical challenges in cannabinoid therapeutics. Understanding how food affects absorption is directly relevant to dosing — a 3-fold difference in blood levels depending on meal timing means the same dose could be sub-therapeutic when fasting or potentially cause more side effects when taken with food. The nanodispersible formulation represents an attempt to improve on this, though the food effect persisted.

This food effect is consistent with what's known about Epidiolex (FDA-approved CBD) and other lipophilic cannabinoids — they're absorbed much better with dietary fat. The nanodispersible formulation was designed to improve bioavailability, but the persistent 3-fold food effect suggests this challenge isn't fully solved. For anyone taking CBD therapeutically, these findings reinforce that consistent dosing relative to meals matters more than most people realize.

Small sample (18 subjects, 9 per arm). Male subjects only — sex differences in CBD pharmacokinetics were not assessed. Single-dose study doesn't capture steady-state kinetics from repeated dosing. Healthy volunteers may not reflect pharmacokinetics in patient populations. The nanodispersible formulation is specific to this manufacturer.